advanced search

Welcome: Guest

log in

Russia Pharmaceuticals and Healthcare Report Q4 2009

Publication Date October 2009
Publisher Business Monitor
Product Type Report
Pages 88
ISBN Number 1748-2135
Product Code BMI03139
Buy this product or for assistance call +44 20 7060 7474

Summary

This quarter BMI introduces 10-year forecasts for the Russian pharmaceutical markets, providing an opportunity to look beyond the current financial crisis and assess the growth potential for the largest and most populous pharmaceutical market in Central and Eastern European (CEE). By 2018, we forecast that the Russian pharmaceutical market will be worth US$50.9bn, representing an 11.28% compound annual growth rate (CAGR) ??

Content

  • Executive Summary
  • SWOT Analysis
  • Russia Political SWOT
  • Russia Economic SWOT
  • Russia Business Environment SWOT
  • Russia Pharmaceuticals And Healthcare Industry SWOT
  • Pharmaceutical Business Environment Ratings
  • Limits of Potential Returns
  • Risk to Realisation of Returns
  • Russia ??
Product features / use
Level General Industry Strategies yes
Data Detailed Market Forecasts yes
Profiles Profiles of Key Companies yes
Features Contains SWOT Analysis yes
Extra Info Consumer Trends Highlighted yes

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>